Form 4: Kodiak Sciences Insider Buys Shares

Sentiment:

Insider Transaction (Form 4)


Baker Bros. Advisors Lp and 5 others reported changes in beneficial ownership of Kodiak Sciences Inc. common stock on September 28, 2026.

Summary

  • Open-market purchase: acquired 534 Common Stock at $79.40 ($42,402) on September 28, 2026; holds 1,606,426 after (Indirect).
  • Open-market purchase: acquired 8,956 Common Stock at $79.40 ($711,147) on September 28, 2026; holds 19,130,090 after (Indirect).
  • Open-market purchase: acquired 17 Common Stock at $79.63 ($1,354) on September 28, 2026; holds 1,606,443 after (Indirect).
  • Open-market purchase: acquired 283 Common Stock at $79.63 ($22,535) on September 28, 2026; holds 19,130,373 after (Indirect).
  • Open-market purchase: acquired 884 Common Stock at $79.71 ($70,462) on September 28, 2026; holds 1,607,327 after (Indirect).
  • Open-market purchase: acquired 14,827 Common Stock at $79.71 ($1,181,825) on September 28, 2026; holds 19,145,200 after (Indirect).
  • Open-market purchase: acquired 404 Common Stock at $80.23 ($32,411) on September 28, 2026; holds 1,607,731 after (Indirect).
  • Open-market purchase: acquired 6,783 Common Stock at $80.23 ($544,172) on September 28, 2026; holds 19,151,983 after (Indirect).
  • Open-market purchase: acquired 61 Common Stock at $80.52 ($4,912) on September 28, 2026; holds 1,607,792 after (Indirect).
  • Open-market purchase: acquired 1,027 Common Stock at $80.52 ($82,694) on September 28, 2026; holds 19,153,010 after (Indirect).
  • Open-market purchase: acquired 1,024 Common Stock at $81.02 ($82,965) on September 28, 2026; holds 1,608,816 after (Indirect).
  • Open-market purchase: acquired 17,159 Common Stock at $81.02 ($1,390,229) on September 28, 2026; holds 19,170,169 after (Indirect).
  • Open-market purchase: acquired 338 Common Stock at $81.20 ($27,446) on September 28, 2026; holds 1,609,154 after (Indirect).
  • Open-market purchase: acquired 5,654 Common Stock at $81.20 ($459,116) on September 28, 2026; holds 19,175,823 after (Indirect).
  • Open-market purchase: acquired 1,044 Common Stock at $81.31 ($84,892) on September 28, 2026; holds 1,610,198 after (Indirect).
  • Open-market purchase: acquired 17,490 Common Stock at $81.31 ($1,422,180) on September 28, 2026; holds 19,193,313 after (Indirect).
  • Open-market purchase: acquired 1,672 Common Stock at $81.82 ($136,797) on September 28, 2026; holds 1,611,870 after (Indirect).
  • Open-market purchase: acquired 28,028 Common Stock at $81.82 ($2,293,144) on September 28, 2026; holds 19,221,341 after (Indirect).
  • Open-market purchase: acquired 39 Common Stock at $81.92 ($3,195) on September 28, 2026; holds 1,611,909 after (Indirect).
  • Open-market purchase: acquired 651 Common Stock at $81.92 ($53,327) on September 28, 2026; holds 19,221,992 after (Indirect).
  • Open-market purchase: acquired 101 Common Stock at $82.68 ($8,351) on September 28, 2026; holds 1,612,010 after (Indirect).
  • Open-market purchase: acquired 1,699 Common Stock at $82.68 ($140,477) on September 28, 2026; holds 19,223,691 after (Indirect).
  • Open-market purchase: acquired 1,167 Common Stock at $83.16 ($97,042) on September 28, 2026; holds 1,613,177 after (Indirect).
  • Open-market purchase: acquired 19,554 Common Stock at $83.16 ($1,626,017) on September 28, 2026; holds 19,243,245 after (Indirect).
  • Open-market purchase: acquired 7,390 Common Stock at $83.95 ($620,399) on September 28, 2026; holds 1,620,567 after (Indirect).
  • Open-market purchase: acquired 123,888 Common Stock at $83.95 ($10,400,546) on September 28, 2026; holds 19,367,133 after (Indirect).
  • Open-market purchase: acquired 6,553 Common Stock at $84.85 ($556,050) on September 28, 2026; holds 1,627,120 after (Indirect).
  • Open-market purchase: acquired 109,842 Common Stock at $84.85 ($9,320,566) on September 28, 2026; holds 19,476,975 after (Indirect).
  • Open-market purchase: acquired 2,322 Common Stock at $85.97 ($199,612) on September 28, 2026; holds 1,629,442 after (Indirect).
  • Open-market purchase: acquired 38,932 Common Stock at $85.97 ($3,346,813) on September 28, 2026; holds 19,515,907 after (Indirect).

Sentiment

Score: 9

Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $34,963,077, committing personal capital to the stock.

Insider Transactions

Baker Bros. Advisors Lp — Director, 10% owner

667, L.P. — Director, 10% owner

Baker Bros. Advisors (GP) LLC — Director, 10% owner

Baker Brothers Life Sciences LP — Director, 10% owner

Felix Baker — Director, 10% owner

Julian Baker — Director, 10% owner

DateTransactionSecuritySharesPriceValueHeld After
2026-09-28Open-market purchaseCommon Stock534$79$42.4K1,606,426
2026-09-28Open-market purchaseCommon Stock8,956$79$711.1K19,130,090
2026-09-28Open-market purchaseCommon Stock17$80$1.4K1,606,443
2026-09-28Open-market purchaseCommon Stock283$80$22.5K19,130,373
2026-09-28Open-market purchaseCommon Stock884$80$70.5K1,607,327
2026-09-28Open-market purchaseCommon Stock14,827$80$1.2M19,145,200
2026-09-28Open-market purchaseCommon Stock404$80$32.4K1,607,731
2026-09-28Open-market purchaseCommon Stock6,783$80$544.2K19,151,983
2026-09-28Open-market purchaseCommon Stock61$81$4.9K1,607,792
2026-09-28Open-market purchaseCommon Stock1,027$81$82.7K19,153,010
2026-09-28Open-market purchaseCommon Stock1,024$81$83.0K1,608,816
2026-09-28Open-market purchaseCommon Stock17,159$81$1.4M19,170,169
2026-09-28Open-market purchaseCommon Stock338$81$27.4K1,609,154
2026-09-28Open-market purchaseCommon Stock5,654$81$459.1K19,175,823
2026-09-28Open-market purchaseCommon Stock1,044$81$84.9K1,610,198
2026-09-28Open-market purchaseCommon Stock17,490$81$1.4M19,193,313
2026-09-28Open-market purchaseCommon Stock1,672$82$136.8K1,611,870
2026-09-28Open-market purchaseCommon Stock28,028$82$2.3M19,221,341
2026-09-28Open-market purchaseCommon Stock39$82$3.2K1,611,909
2026-09-28Open-market purchaseCommon Stock651$82$53.3K19,221,992
2026-09-28Open-market purchaseCommon Stock101$83$8.4K1,612,010
2026-09-28Open-market purchaseCommon Stock1,699$83$140.5K19,223,691
2026-09-28Open-market purchaseCommon Stock1,167$83$97.0K1,613,177
2026-09-28Open-market purchaseCommon Stock19,554$83$1.6M19,243,245
2026-09-28Open-market purchaseCommon Stock7,390$84$620.4K1,620,567
2026-09-28Open-market purchaseCommon Stock123,888$84$10.4M19,367,133
2026-09-28Open-market purchaseCommon Stock6,553$85$556.1K1,627,120
2026-09-28Open-market purchaseCommon Stock109,842$85$9.3M19,476,975
2026-09-28Open-market purchaseCommon Stock2,322$86$199.6K1,629,442
2026-09-28Open-market purchaseCommon Stock38,932$86$3.3M19,515,907

Key Dates

DateDescription
2026-09-28Open-market purchase (534 shares)
2026-09-28Open-market purchase (8,956 shares)
2026-09-28Open-market purchase (17 shares)
2026-09-28Open-market purchase (283 shares)
2026-09-28Open-market purchase (884 shares)
2026-09-28Open-market purchase (14,827 shares)
2026-09-28Open-market purchase (404 shares)
2026-09-28Open-market purchase (6,783 shares)
2026-09-28Open-market purchase (61 shares)
2026-09-28Open-market purchase (1,027 shares)
2026-09-28Open-market purchase (1,024 shares)
2026-09-28Open-market purchase (17,159 shares)
2026-09-28Open-market purchase (338 shares)
2026-09-28Open-market purchase (5,654 shares)
2026-09-28Open-market purchase (1,044 shares)
2026-09-28Open-market purchase (17,490 shares)
2026-09-28Open-market purchase (1,672 shares)
2026-09-28Open-market purchase (28,028 shares)
2026-09-28Open-market purchase (39 shares)
2026-09-28Open-market purchase (651 shares)
2026-09-28Open-market purchase (101 shares)
2026-09-28Open-market purchase (1,699 shares)
2026-09-28Open-market purchase (1,167 shares)
2026-09-28Open-market purchase (19,554 shares)
2026-09-28Open-market purchase (7,390 shares)
2026-09-28Open-market purchase (123,888 shares)
2026-09-28Open-market purchase (6,553 shares)
2026-09-28Open-market purchase (109,842 shares)
2026-09-28Open-market purchase (2,322 shares)
2026-09-28Open-market purchase (38,932 shares)

Keywords

insider transaction, Form 4, KOD, Kodiak Sciences Inc., bullish, Baker Bros. Advisors Lp, 667, L.P., Baker Bros. Advisors (GP) LLC, Baker Brothers Life Sciences LP, Felix Baker, Julian Baker

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.